F-star Biotech Raises €8 Million
F-star Biotech, a Vienna, Austria-based antibody engineering company, has raised €8 million in new Series A funding. MP Healthcare Venture Management and Merck Serono Ventures co-led the round, and were joined by return backers Atlas Venture, Aescap Venture, Novo Ventures and TVM Capital.
6 January 2010•5 mins read
